-
Product Insights
NewInduced Myeloid Leukemia Cell Differentiation Protein Mcl 1 – Drugs In Development, 2024
The Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 pipeline drugs market research report outlays comprehensive information on the Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Infectious Disease which include indications of Oncology, Solid Tumor, and Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. It also reviews key players...
-
Product Insights
NewEnoyl [Acyl Carrier Protein] Reductase [NADH] FabI – Drugs In Development, 2024
The Enoyl [Acyl Carrier Protein] Reductase [NADH] FabI pipeline drugs market research report outlays comprehensive information on the Enoyl [Acyl Carrier Protein] Reductase [NADH] FabI targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease which include indications of Tuberculosis, and Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. It also reviews key players involved in Enoyl [Acyl Carrier Protein]...
-
Product Insights
NewBcl 2 Like Protein 1 – Drugs In Development, 2024
The Bcl 2 Like Protein 1 pipeline drugs market research report outlays comprehensive information on the Bcl 2 Like Protein 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Infectious Disease, and Musculoskeletal Disorders which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections, and Fibrosis. It also reviews key players...
-
Product Insights
NewATP Dependent Clp Protease Proteolytic Subunit Mitochondrial – Drugs In Development, 2024
The ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial pipeline drugs market research report outlays comprehensive information on the ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Oncology, Respiratory, and Dermatology which include indications of Staphylococcus aureus Infections, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections, Ovarian Cancer, Endometrial Cancer, Pneumonia, and...
-
Product Insights
NewPenicillin Binding Protein 2 – Drugs In Development, 2024
The Penicillin Binding Protein 2 pipeline drugs market research report outlays comprehensive information on the Penicillin Binding Protein 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Genito Urinary System, Respiratory, and Cardiovascular which include indications of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections, Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections, Urinary Tract Infections, Pneumonia, and Bacterial Endocarditis. It...
-
Product Insights
NewSerine/Threonine Protein Kinase Pim – Drugs In Development, 2024
The Serine/Threonine Protein Kinase Pim pipeline drugs market research report outlays comprehensive information on the Serine/Threonine Protein Kinase Pim targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Gastrointestinal, and Infectious Disease which include indications of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Oncology, Psoriasis, Rheumatoid Arthritis, Inflammatory Bowel Disease, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections, and...
-
Product Insights
New30S Ribosomal Subunit – Drugs In Development, 2024
The 30S Ribosomal Subunit pipeline drugs market research report outlays comprehensive information on the 30S Ribosomal Subunit targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Respiratory, Genito Urinary System, and Ear Nose Throat Disorders which include indications of Skin And Skin Structure Infections (SSSI) Caused By Bacteria, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections, Cystic Fibrosis, Bronchiectasis,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EXS-617 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EXS-617 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EXS-617 in Colorectal Cancer Drug Details: EXS-617 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CAL-02 in Community-Acquired Bacterial Pneumonia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CAL-02 in Community-Acquired Bacterial Pneumonia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CAL-02 in Community-Acquired Bacterial Pneumonia Drug Details: CAL-02 (combioxin) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ceftobiprole Medocaril in Sepsis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ceftobiprole Medocaril in Sepsis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ceftobiprole Medocaril in Sepsis Drug Details: Ceftobiprole medocaril (Zeftera/Zevtera/Mabelio) a broad-spectrum...